A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia

Research output: Contribution to journalLetterpeer-review

4 Scopus citations

Fingerprint Dive into the research topics of 'A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia'. Together they form a unique fingerprint.